Oncology drugs · CNS therapies · Anti-infective & metabolic drugs
Hansoh Pharmaceutical Group
A large Chinese innovative pharma company developing prescription drugs in oncology, CNS, and anti-infectives. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
Business categories Pharmaceuticals & Biotechnology · Biopharma & Life Sciences · primary Oncology & ADCs · Biopharma & Life Sciences
Other companies in the same category
- Pharmaceuticals & Biotechnology: Alnylam Pharmaceuticals · Regeneron Pharmaceuticals · Moderna · AbbVie · Lilly (Eli)
- Oncology & ADCs: Bristol-Myers Squibb Company · Merck & Co. · LigaChem Biosciences · Daiichi Sankyo · HLB
3692.HK Updated Jul 11, 2026 2 AI consumers· 2 recurring
Annual return · 2026-10-09'21-62.1%'22+1.1%'23-26.1%'24+55.2%'25+118.5%YTD-17.1%
Money in ▸·
Hansoh Pharmaceutical Groupapprox. CN¥10.1B
▸ Money out·
Financials & Segments
- Total revenue · approx. CN¥10.1B (FY2023)
- Segments · Oncology · Central nervous system · Anti-infective & metabolic
Revenue from
No refined links yet.
Pays to
No refined links yet.